According to cognitive market research, the global antibiotics market size was valued at USD xx billion in 2024 and is expected to reach USD xx billion at a CAGR of xx% during the forecast period. 


Antibiotics are medicines that fight bacterial infections in people and animals. These medications aid in destroying or inhibiting the development of microorganisms.
Antibiotic use has remarkably grown in recent months as a result of the COVID-19 pandemic's requirement to prevent hospital stays and extended illnesses.
Gram-positive and Gram-negative bacteria can be treated with a variety of broad-spectrum medications, including Cephalosporin and Penicillin.
Antimicrobial resistance (AMR) arises from the evolution of drug-resistant bacteria, viruses, parasites, or fungi.
Advances in molecular biology, biotechnology, and drug discovery methodologies contribute to increasing the efficacy and efficiency of antibiotic development.
•North America is expected to dominate the antibiotics market over the forecast period. The region's high burden of infectious illnesses and an aging population are contributing reasons for the rise in demand and usage of antibiotics.

Chapter 1 2026 Geopolitical Outlook - Antibiotics Market Detailed Analysis
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
Chapter 3 Global Market Analysis
3.1 Global Antibiotics Revenue Market Size, Trend Analysis 2022 - 2034
3.2 Global Antibiotics Market Size By Regions 2022 - 2034
3.2.1 Global Antibiotics Revenue Market Size By Region
3.3 Global Antibiotics Market Size By Drug Class 2022 - 2034
3.3.1 Cephalosporins Market Size
3.3.2 Penicillin Market Size
3.3.3 Fluoroquinolones Market Size
3.3.4 Macrolides Market Size
3.3.5 Carbapenems Market Size
3.3.6 Aminoglycosides Market Size
3.3.7 Sulfonamides Market Size
3.3.8 Others Market Size
3.4 Global Antibiotics Market Size By Type 2022 - 2034
3.4.1 Generic Market Size
3.4.2 Branded Market Size
3.5 Global Antibiotics Market Size By Mechanism of Action 2022 - 2034
3.5.1 Cell Wall Synthesis Inhibitors Market Size
3.5.2 Protein Synthesis Inhibitors Market Size
3.5.3 DNA Synthesis Inhibitors Market Size
3.5.4 RNA Synthesis Inhibitors Market Size
3.5.5 Mycolic Acid Inhibitors Market Size
3.5.6 Others Market Size
3.6 Global Antibiotics Market Size By Spectrum Of Activity for 2022 - 2034
3.6.1 Broad-spectrum Antibiotic Market Size
3.6.2 Narrow-spectrum Antibiotic Market Size
3.7 Global Antibiotics Market Size By Infection Type for 2022 - 2034
3.7.1 Respiratory Tract Infections (RTIs) Market Size
3.7.2 Urinary Tract Infections (UTIs) Market Size
3.7.3 Skin and Soft Tissue Infections (SSTIs) Market Size
3.7.4 Gastrointestinal Infections Market Size
3.7.5 Sexually Transmitted Infections (STIs) Market Size
3.7.6 Bloodstream Infections (Sepsis) Market Size
3.7.7 Tuberculosis (TB) Market Size
3.7.8 Others Market Size
3.8 Global Antibiotics Market Size By Age Group for 2022 - 2034
3.8.1 Children Market Size
3.8.2 Adults Market Size
3.8.3 Geriatric Market Size
3.8.1 Children Market Size
3.8.2 Adults Market Size
3.8.3 Geriatric Market Size
3.9 Global Antibiotics Market Size By Route of Administration for 2022 - 2034
3.9.1 Oral Market Size
3.9.2 Parenteral Market Size
3.9.3 Topical Market Size
3.9.4 Others Market Size
3.10 Global Antibiotics Market Size By Distribution Channel for 2022 - 2034
3.10.1 Hospital Pharmacy Market Size
3.10.2 Retail Pharmacy Market Size
3.10.3 Online Pharmacy Market Size
3.11 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
3.12 Executive Summary Global Market (2021 vs 2025 vs 2033)
3.12.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
3.12.2 Global Market Revenue Split By Drug Class
3.12.3 Global Market Revenue Split By Type
3.12.4 Global Market Revenue Split By Mechanism of Action
3.12.5 Global Market Revenue Split By Spectrum Of Activity
3.12.6 Global Market Revenue Split By Infection Type
3.12.7 Global Market Revenue Split By Route of Administration
3.12.8 Global Market Revenue Split By Distribution Channel
3.12.9 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Chapter 4 North America Market Analysis
4.1 North America Antibiotics Market Outlook
4.1.1 North America Antibiotics Market Size 2022 - 2034
4.1.2 North America Antibiotics Market Size By Country 2022 - 2034
4.1.3 North America Antibiotics Market Size by Drug Class 2022 - 2034
4.1.3.1 North America Cephalosporins Market Size
4.1.3.2 North America Penicillin Market Size
4.1.3.3 North America Fluoroquinolones Market Size
4.1.3.4 North America Macrolides Market Size
4.1.3.5 North America Carbapenems Market Size
4.1.3.6 North America Aminoglycosides Market Size
4.1.3.7 North America Sulfonamides Market Size
4.1.3.8 North America Others Market Size
4.1.4 North America Antibiotics Market Size by Type 2022 - 2034
4.1.4.1 North America Generic Market Size
4.1.4.2 North America Branded Market Size
4.1.5 North America Antibiotics Market Size by Mechanism of Action 2022 - 2034
4.1.5.1 North America Cell Wall Synthesis Inhibitors Market Size
4.1.5.2 North America Protein Synthesis Inhibitors Market Size
4.1.5.3 North America DNA Synthesis Inhibitors Market Size
4.1.5.4 North America RNA Synthesis Inhibitors Market Size
4.1.5.5 North America Mycolic Acid Inhibitors Market Size
4.1.5.6 North America Others Market Size
4.1.6 North America Antibiotics Market Size by Spectrum Of Activity 2022 - 2034
4.1.6.1 North America Broad-spectrum Antibiotic Market Size
4.1.6.2 North America Narrow-spectrum Antibiotic Market Size
4.1.7 North America Antibiotics Market Size by Infection Type 2022 - 2034
4.1.7.1 North America Respiratory Tract Infections (RTIs) Market Size
4.1.7.2 North America Urinary Tract Infections (UTIs) Market Size
4.1.7.3 North America Skin and Soft Tissue Infections (SSTIs) Market Size
4.1.7.4 North America Gastrointestinal Infections Market Size
4.1.7.5 North America Sexually Transmitted Infections (STIs) Market Size
4.1.7.6 North America Bloodstream Infections (Sepsis) Market Size
4.1.7.7 North America Tuberculosis (TB) Market Size
4.1.7.8 North America Others Market Size
4.1.8 North America Antibiotics Market Size by Age Group 2022 - 2034
4.1.8.1 North America Children Market Size
4.1.8.2 North America Adults Market Size
4.1.8.3 North America Geriatric Market Size
4.1.9 North America Antibiotics Market Size by Route of Administration 2022 - 2034
4.1.9.1 North America Oral Market Size
4.1.9.2 North America Parenteral Market Size
4.1.9.3 North America Topical Market Size
4.1.9.4 North America Others Market Size
4.1.10 North America Antibiotics Market Size by Distribution Channel 2022 - 2034
4.1.10.1 North America Hospital Pharmacy Market Size
4.1.10.2 North America Retail Pharmacy Market Size
4.1.10.3 North America Online Pharmacy Market Size
Chapter 5 Europe Market Analysis
5.1 Europe Antibiotics Market Outlook
5.1.1 Europe Antibiotics Market Size 2022 - 2034
5.1.2 Europe Antibiotics Market Size By Country 2022 - 2034
5.1.3 Europe Antibiotics Market Size by Drug Class 2022 - 2034
5.1.3.1 Europe Cephalosporins Market Size
5.1.3.2 Europe Penicillin Market Size
5.1.3.3 Europe Fluoroquinolones Market Size
5.1.3.4 Europe Macrolides Market Size
5.1.3.5 Europe Carbapenems Market Size
5.1.3.6 Europe Aminoglycosides Market Size
5.1.3.7 Europe Sulfonamides Market Size
5.1.3.8 Europe Others Market Size
5.1.4 Europe Antibiotics Market Size by Type 2022 - 2034
5.1.4.1 Europe Generic Market Size
5.1.4.2 Europe Branded Market Size
5.1.5 Europe Antibiotics Market Size by Mechanism of Action 2022 - 2034
5.1.5.1 Europe Cell Wall Synthesis Inhibitors Market Size
5.1.5.2 Europe Protein Synthesis Inhibitors Market Size
5.1.5.3 Europe DNA Synthesis Inhibitors Market Size
5.1.5.4 Europe RNA Synthesis Inhibitors Market Size
5.1.5.5 Europe Mycolic Acid Inhibitors Market Size
5.1.5.6 Europe Others Market Size
5.1.6 Europe Antibiotics Market Size by Spectrum Of Activity 2022 - 2034
5.1.6.1 Europe Broad-spectrum Antibiotic Market Size
5.1.6.2 Europe Narrow-spectrum Antibiotic Market Size
5.1.7 Europe Antibiotics Market Size by Infection Type 2022 - 2034
5.1.7.1 Europe Respiratory Tract Infections (RTIs) Market Size
5.1.7.2 Europe Urinary Tract Infections (UTIs) Market Size
5.1.7.3 Europe Skin and Soft Tissue Infections (SSTIs) Market Size
5.1.7.4 Europe Gastrointestinal Infections Market Size
5.1.7.5 Europe Sexually Transmitted Infections (STIs) Market Size
5.1.7.6 Europe Bloodstream Infections (Sepsis) Market Size
5.1.7.7 Europe Tuberculosis (TB) Market Size
5.1.7.8 Europe Others Market Size
5.1.8 Europe Antibiotics Market Size by Age Group 2022 - 2034
5.1.8.1 Europe Children Market Size
5.1.8.2 Europe Adults Market Size
5.1.8.3 Europe Geriatric Market Size
5.1.9 Europe Antibiotics Market Size by Route of Administration 2022 - 2034
5.1.10 Europe Antibiotics Market Size by Distribution Channel 2022 - 2034
5.1.10.1 Europe Hospital Pharmacy Market Size
5.1.10.2 Europe Retail Pharmacy Market Size
5.1.10.3 Europe Online Pharmacy Market Size
Chapter 6 Asia Pacific Market Analysis
6.1 Asia Pacific Antibiotics Market Outlook
6.1.1 Asia Pacific Antibiotics Market Size 2022 - 2034
6.1.2 Asia Pacific Antibiotics Market Size By Country 2022 - 2034
6.1.3 Asia Pacific Antibiotics Market Size by Drug Class 2022 - 2034
6.1.3.1 Asia Pacific Cephalosporins Market Size
6.1.3.2 Asia Pacific Penicillin Market Size
6.1.3.3 Asia Pacific Fluoroquinolones Market Size
6.1.3.4 Asia Pacific Macrolides Market Size
6.1.3.5 Asia Pacific Carbapenems Market Size
6.1.3.6 Asia Pacific Aminoglycosides Market Size
6.1.3.7 Asia Pacific Sulfonamides Market Size
6.1.3.8 Asia Pacific Others Market Size
6.1.4 Asia Pacific Antibiotics Market Size by Type 2022 - 2034
6.1.4.1 Asia Pacific Generic Market Size
6.1.4.2 Asia Pacific Branded Market Size
6.1.5 Asia Pacific Antibiotics Market Size by Mechanism of Action 2022 - 2034
6.1.5.1 Asia Pacific Cell Wall Synthesis Inhibitors Market Size
6.1.5.2 Asia Pacific Protein Synthesis Inhibitors Market Size
6.1.5.3 Asia Pacific DNA Synthesis Inhibitors Market Size
6.1.5.4 Asia Pacific RNA Synthesis Inhibitors Market Size
6.1.5.5 Asia Pacific Mycolic Acid Inhibitors Market Size
6.1.5.6 Asia Pacific Others Market Size
6.1.6 Asia Pacific Antibiotics Market Size by Spectrum Of Activity 2022 - 2034
6.1.6.1 Asia Pacific Broad-spectrum Antibiotic Market Size
6.1.6.2 Asia Pacific Narrow-spectrum Antibiotic Market Size
6.1.7 Asia Pacific Antibiotics Market Size by Infection Type 2022 - 2034
6.1.7.1 Asia Pacific Respiratory Tract Infections (RTIs) Market Size
6.1.7.2 Asia Pacific Urinary Tract Infections (UTIs) Market Size
6.1.7.3 Asia Pacific Skin and Soft Tissue Infections (SSTIs) Market Size
6.1.7.4 Asia Pacific Gastrointestinal Infections Market Size
6.1.7.5 Asia Pacific Sexually Transmitted Infections (STIs) Market Size
6.1.7.6 Asia Pacific Bloodstream Infections (Sepsis) Market Size
6.1.7.7 Asia Pacific Tuberculosis (TB) Market Size
6.1.7.8 Asia Pacific Others Market Size
6.1.8 Asia Pacific Antibiotics Market Size by Age Group 2022 - 2034
6.1.8.1 Asia Pacific Children Market Size
6.1.8.2 Asia Pacific Adults Market Size
6.1.8.3 Asia Pacific Geriatric Market Size
6.1.9 Asia Pacific Antibiotics Market Size by Route of Administration 2022 - 2034
6.1.9.1 Asia Pacific Oral Market Size
6.1.9.2 Asia Pacific Parenteral Market Size
6.1.9.3 Asia Pacific Topical Market Size
6.1.9.4 Asia Pacific Others Market Size
6.1.10 Asia Pacific Antibiotics Market Size by Distribution Channel 2022 - 2034
6.1.10.1 Asia Pacific Hospital Pharmacy Market Size
6.1.10.2 Asia Pacific Retail Pharmacy Market Size
6.1.10.3 Asia Pacific Online Pharmacy Market Size
Chapter 7 South America Market Analysis
7.1 South America Antibiotics Market Outlook
7.1.1 South America Antibiotics Market Size 2022 - 2034
7.1.2 South America Antibiotics Market Size By Country 2022 - 2034
7.1.3 South America Antibiotics Market Size by Drug Class 2022 - 2034
7.1.3.1 South America Cephalosporins Market Size
7.1.3.2 South America Penicillin Market Size
7.1.3.3 South America Fluoroquinolones Market Size
7.1.3.4 South America Macrolides Market Size
7.1.3.5 South America Carbapenems Market Size
7.1.3.6 South America Aminoglycosides Market Size
7.1.3.7 South America Sulfonamides Market Size
7.1.3.8 South America Others Market Size
7.1.4 South America Antibiotics Market Size by Type 2022 - 2034
7.1.4.1 South America Generic Market Size
7.1.4.2 South America Branded Market Size
7.1.5 South America Antibiotics Market Size by Mechanism of Action 2022 - 2034
7.1.5.1 South America Cell Wall Synthesis Inhibitors Market Size
7.1.5.2 South America Protein Synthesis Inhibitors Market Size
7.1.5.3 South America DNA Synthesis Inhibitors Market Size
7.1.5.4 South America RNA Synthesis Inhibitors Market Size
7.1.5.5 South America Mycolic Acid Inhibitors Market Size
7.1.5.6 South America Others Market Size
7.1.6 South America Antibiotics Market Size by Spectrum Of Activity 2022 - 2034
7.1.6.1 South America Broad-spectrum Antibiotic Market Size
7.1.6.2 South America Narrow-spectrum Antibiotic Market Size
7.1.7 South America Antibiotics Market Size by Infection Type 2022 - 2034
7.1.7.1 South America Respiratory Tract Infections (RTIs) Market Size
7.1.7.2 South America Urinary Tract Infections (UTIs) Market Size
7.1.7.3 South America Skin and Soft Tissue Infections (SSTIs) Market Size
7.1.7.4 South America Gastrointestinal Infections Market Size
7.1.7.5 South America Sexually Transmitted Infections (STIs) Market Size
7.1.7.6 South America Bloodstream Infections (Sepsis) Market Size
7.1.7.7 South America Tuberculosis (TB) Market Size
7.1.7.8 South America Others Market Size
7.1.8 South America Antibiotics Market Size by Age Group 2022 - 2034
7.1.8.1 South America Children Market Size
7.1.8.2 South America Adults Market Size
7.1.8.3 South America Geriatric Market Size
7.1.9 South America Antibiotics Market Size by Route of Administration 2022 - 2034
7.1.9.1 South America Oral Market Size
7.1.9.2 South America Parenteral Market Size
7.1.9.3 South America Topical Market Size
7.1.9.4 South America Others Market Size
7.1.10 South America Antibiotics Market Size by Distribution Channel 2022 - 2034
7.1.10.1 South America Hospital Pharmacy Market Size
7.1.10.2 South America Retail Pharmacy Market Size
7.1.10.3 South America Online Pharmacy Market Size
Chapter 8 Middle East Market Analysis
8.1 Middle East Antibiotics Market Outlook
8.1.1 Middle East Antibiotics Market Size 2022 - 2034
8.1.2 Middle East Antibiotics Market Size By Country 2022 - 2034
8.1.3 Middle East Antibiotics Market Size by Drug Class 2022 - 2034
8.1.3.1 Middle East Cephalosporins Market Size
8.1.3.2 Middle East Penicillin Market Size
8.1.3.3 Middle East Fluoroquinolones Market Size
8.1.3.4 Middle East Macrolides Market Size
8.1.3.5 Middle East Carbapenems Market Size
8.1.3.6 Middle East Aminoglycosides Market Size
8.1.3.7 Middle East Sulfonamides Market Size
8.1.3.8 Middle East Others Market Size
8.1.4 Middle East Antibiotics Market Size by Type 2022 - 2034
8.1.4.1 Middle East Generic Market Size
8.1.4.2 Middle East Branded Market Size
8.1.5 Middle East Antibiotics Market Size by Mechanism of Action 2022 - 2034
8.1.5.1 Middle East Cell Wall Synthesis Inhibitors Market Size
8.1.5.2 Middle East Protein Synthesis Inhibitors Market Size
8.1.5.3 Middle East DNA Synthesis Inhibitors Market Size
8.1.5.4 Middle East RNA Synthesis Inhibitors Market Size
8.1.5.5 Middle East Mycolic Acid Inhibitors Market Size
8.1.5.6 Middle East Others Market Size
8.1.6 Middle East Antibiotics Market Size by Spectrum Of Activity 2022 - 2034
8.1.6.1 Middle East Broad-spectrum Antibiotic Market Size
8.1.6.2 Middle East Narrow-spectrum Antibiotic Market Size
8.1.7 Middle East Antibiotics Market Size by Infection Type 2022 - 2034
8.1.7.1 Middle East Respiratory Tract Infections (RTIs) Market Size
8.1.7.2 Middle East Urinary Tract Infections (UTIs) Market Size
8.1.7.3 Middle East Skin and Soft Tissue Infections (SSTIs) Market Size
8.1.7.4 Middle East Gastrointestinal Infections Market Size
8.1.7.5 Middle East Sexually Transmitted Infections (STIs) Market Size
8.1.7.6 Middle East Bloodstream Infections (Sepsis) Market Size
8.1.7.7 Middle East Tuberculosis (TB) Market Size
8.1.7.8 Middle East Others Market Size
8.1.8 Middle East Antibiotics Market Size by Age Group 2022 - 2034
8.1.8.1 Middle East Children Market Size
8.1.8.2 Middle East Adults Market Size
8.1.8.3 Middle East Geriatric Market Size
8.1.9 Middle East Antibiotics Market Size by Route of Administration 2022 - 2034
8.1.9.1 Middle East Oral Market Size
8.1.9.2 Middle East Parenteral Market Size
8.1.9.3 Middle East Topical Market Size
8.1.9.4 Middle East Others Market Size
8.1.10 Middle East Antibiotics Market Size by Distribution Channel 2022 - 2034
8.1.10.1 Middle East Hospital Pharmacy Market Size
8.1.10.2 Middle East Retail Pharmacy Market Size
8.1.10.3 Middle East Online Pharmacy Market Size
Chapter 9 Africa Market Analysis
9.1 Africa Antibiotics Market Outlook
9.1.1 Africa Antibiotics Market Size 2022 - 2034
9.1.2 Africa Antibiotics Market Size By Country 2022 - 2034
9.1.3 Africa Antibiotics Market Size by Drug Class 2022 - 2034
9.1.3.1 Africa Cephalosporins Market Size
9.1.3.2 Africa Penicillin Market Size
9.1.3.3 Africa Fluoroquinolones Market Size
9.1.3.4 Africa Macrolides Market Size
9.1.3.5 Africa Carbapenems Market Size
9.1.3.6 Africa Aminoglycosides Market Size
9.1.3.7 Africa Sulfonamides Market Size
9.1.3.8 Africa Others Market Size
9.1.4 Africa Antibiotics Market Size by Type 2022 - 2034
9.1.4.1 Africa Generic Market Size
9.1.4.2 Africa Branded Market Size
9.1.5 Africa Antibiotics Market Size by Mechanism of Action 2022 - 2034
9.1.5.1 Africa Cell Wall Synthesis Inhibitors Market Size
9.1.5.2 Africa Protein Synthesis Inhibitors Market Size
9.1.5.3 Africa DNA Synthesis Inhibitors Market Size
9.1.5.4 Africa RNA Synthesis Inhibitors Market Size
9.1.5.5 Africa Mycolic Acid Inhibitors Market Size
9.1.5.6 Africa Others Market Size
9.1.6 Africa Antibiotics Market Size by Spectrum Of Activity 2022 - 2034
9.1.6.1 Africa Broad-spectrum Antibiotic Market Size
9.1.6.2 Africa Narrow-spectrum Antibiotic Market Size
9.1.7 Africa Antibiotics Market Size by Infection Type 2022 - 2034
9.1.7.1 Africa Respiratory Tract Infections (RTIs) Market Size
9.1.7.2 Africa Urinary Tract Infections (UTIs) Market Size
9.1.7.3 Africa Skin and Soft Tissue Infections (SSTIs) Market Size
9.1.7.4 Africa Gastrointestinal Infections Market Size
9.1.7.5 Africa Sexually Transmitted Infections (STIs) Market Size
9.1.7.6 Africa Bloodstream Infections (Sepsis) Market Size
9.1.7.7 Africa Tuberculosis (TB) Market Size
9.1.7.8 Africa Others Market Size
9.1.8 Africa Antibiotics Market Size by Age Group 2022 - 2034
9.1.8.1 Africa Children Market Size
9.1.8.2 Africa Adults Market Size
9.1.8.3 Africa Geriatric Market Size
9.1.9 Africa Antibiotics Market Size by Route of Administration 2022 - 2034
9.1.9.1 Africa Oral Market Size
9.1.9.2 Africa Parenteral Market Size
9.1.9.3 Africa Topical Market Size
9.1.9.4 Africa Others Market Size
9.1.10 Africa Antibiotics Market Size by Distribution Channel 2022 - 2034
9.1.10.1 Africa Hospital Pharmacy Market Size
9.1.10.2 Africa Retail Pharmacy Market Size
9.1.10.3 Africa Online Pharmacy Market Size
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
10.1 Top Competitors Analysis
10.1.1 Global Antibiotics Market Revenue and Share by Key Players
10.1.2 Top Players Ranking 2024
10.1.3 New Product Launch Analysis
10.1.4 Industry Mergers and Acquisition Analysis
10.2 Company Profile (Data Subject to Availability) Sample Format
10.2.1 AbbVie Inc.
10.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.1.2 Business Overview
10.2.1.3 Financials (Subject to data availability)
10.2.1.4 R&D Investment (Subject to data availability)
10.2.1.5 Product Types Specification
10.2.1.6 Business Strategy
10.2.1.7 Recent Developments
10.2.1.8 Management Change
10.2.1.9 S.W.O.T Analysis
10.2.2 Pfizer Inc.
10.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.2.2 Business Overview
10.2.2.3 Financials (Subject to data availability)
10.2.2.4 R&D Investment (Subject to data availability)
10.2.2.5 Product Types Specification
10.2.2.6 Business Strategy
10.2.2.7 Recent Developments
10.2.2.8 Management Change
10.2.2.9 S.W.O.T Analysis
10.2.3 Lupin Pharmaceuticals Inc.
10.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.3.2 Business Overview
10.2.3.3 Financials (Subject to data availability)
10.2.3.4 R&D Investment (Subject to data availability)
10.2.3.5 Product Types Specification
10.2.3.6 Business Strategy
10.2.3.7 Recent Developments
10.2.3.8 Management Change
10.2.3.9 S.W.O.T Analysis
10.2.4 Novartis AG
10.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.4.2 Business Overview
10.2.4.3 Financials (Subject to data availability)
10.2.4.4 R&D Investment (Subject to data availability)
10.2.4.5 Product Types Specification
10.2.4.6 Business Strategy
10.2.4.7 Recent Developments
10.2.4.8 Management Change
10.2.4.9 S.W.O.T Analysis
10.2.5 Teva Pharmaceutical Industries Ltd.
10.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.5.2 Business Overview
10.2.5.3 Financials (Subject to data availability)
10.2.5.4 R&D Investment (Subject to data availability)
10.2.5.5 Product Types Specification
10.2.5.6 Business Strategy
10.2.5.7 Recent Developments
10.2.5.8 Management Change
10.2.5.9 S.W.O.T Analysis
10.2.6 Viatris Inc.
10.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.6.2 Business Overview
10.2.6.3 Financials (Subject to data availability)
10.2.6.4 R&D Investment (Subject to data availability)
10.2.6.5 Product Types Specification
10.2.6.6 Business Strategy
10.2.6.7 Recent Developments
10.2.6.8 Management Change
10.2.6.9 S.W.O.T Analysis
10.2.7 Merck & Co. Inc.
10.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.7.2 Business Overview
10.2.7.3 Financials (Subject to data availability)
10.2.7.4 R&D Investment (Subject to data availability)
10.2.7.5 Product Types Specification
10.2.7.6 Business Strategy
10.2.7.7 Recent Developments
10.2.7.8 Management Change
10.2.7.9 S.W.O.T Analysis
10.2.8 Cipla Inc.
10.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.8.2 Business Overview
10.2.8.3 Financials (Subject to data availability)
10.2.8.4 R&D Investment (Subject to data availability)
10.2.8.5 Product Types Specification
10.2.8.6 Business Strategy
10.2.8.7 Recent Developments
10.2.8.8 Management Change
10.2.8.9 S.W.O.T Analysis
10.2.9 Shionogi & Co. Ltd.
10.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.9.2 Business Overview
10.2.9.3 Financials (Subject to data availability)
10.2.9.4 R&D Investment (Subject to data availability)
10.2.9.5 Product Types Specification
10.2.9.6 Business Strategy
10.2.9.7 Recent Developments
10.2.9.8 Management Change
10.2.9.9 S.W.O.T Analysis
10.2.10 KYORIN Pharmaceutical Co. Ltd.
10.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.10.2 Business Overview
10.2.10.3 Financials (Subject to data availability)
10.2.10.4 R&D Investment (Subject to data availability)
10.2.10.5 Product Types Specification
10.2.10.6 Business Strategy
10.2.10.7 Recent Developments
10.2.10.8 Management Change
10.2.10.9 S.W.O.T Analysis
10.2.11 GSK plc
10.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.11.2 Business Overview
10.2.11.3 Financials (Subject to data availability)
10.2.11.4 R&D Investment (Subject to data availability)
10.2.11.5 Product Types Specification
10.2.11.6 Business Strategy
10.2.11.7 Recent Developments
10.2.11.8 Management Change
10.2.11.9 S.W.O.T Analysis
10.2.12 Nabriva Therapeutics PLC
10.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.12.2 Business Overview
10.2.12.3 Financials (Subject to data availability)
10.2.12.4 R&D Investment (Subject to data availability)
10.2.12.5 Product Types Specification
10.2.12.6 Business Strategy
10.2.12.7 Recent Developments
10.2.12.8 Management Change
10.2.12.9 S.W.O.T Analysis
Chapter 11 Qualitative Analysis (Subject to Data Availability)
11.1 Market Drivers
11.2 Market Restraints
11.3 Market Trends
11.4 Market Opportunity
11.5 Technological Road Map (Subject to Data Availability)
11.6 Product Life Cycle (Subject to Data Availability)
11.7 Consumer Preference Analysis
11.8 Market Attractiveness Analysis
11.9 PESTEL Analysis
11.9.1 Political Factors
11.9.2 Economic Factors
11.9.3 Social Factors
11.9.4 Technological Factors
11.9.5 Legal Factors
11.9.6 Environmental Factors
11.10 Industrial Chain Analysis (Subject to Data Availability)
11.10.1 Industry Chain Analysis
11.10.2 Manufacturing Cost Analysis
11.10.3 Supply Side Analysis
11.10.3.1 Raw Material Analysis
11.10.3.2 Raw Material Procurement Analysis
11.10.3.3 Raw Material Price Trend Analysis
11.11 Porter’s Five Forces Analysis
11.11.1 Bargaining Power of Suppliers
11.11.2 Bargaining Power of Buyers
11.11.3 Threat of New Entrants
11.11.4 Threat of Substitutes
11.11.5 Degree of Competition
11.12 Patent Analysis (Subject to Data Availability)
11.13 ESG Analysis
Chapter 12 Market Split by Drug Class Analysis 2022 - 2034
12.1 Cephalosporins
12.1.1 Global Antibiotics Revenue Market Size and Share by Cephalosporins 2022 - 2034
12.2 Penicillin
12.2.1 Global Antibiotics Revenue Market Size and Share by Penicillin 2022 - 2034
12.3 Fluoroquinolones
12.3.1 Global Antibiotics Revenue Market Size and Share by Fluoroquinolones 2022 - 2034
12.4 Macrolides
12.4.1 Global Antibiotics Revenue Market Size and Share by Macrolides 2022 - 2034
12.5 Carbapenems
12.5.1 Global Antibiotics Revenue Market Size and Share by Carbapenems 2022 - 2034
12.6 Aminoglycosides
12.6.1 Global Antibiotics Revenue Market Size and Share by Aminoglycosides 2022 - 2034
12.7 Sulfonamides
12.7.1 Global Antibiotics Revenue Market Size and Share by Sulfonamides 2022 - 2034
12.8 Others
12.8.1 Global Antibiotics Revenue Market Size and Share by Others 2022 - 2034
Chapter 13 Market Split by Type Analysis 2022 - 2034
13.1 Generic
13.1.1 Global Antibiotics Revenue Market Size and Share by Generic 2022 - 2034
13.2 Branded
13.2.1 Global Antibiotics Revenue Market Size and Share by Branded 2022 - 2034
Chapter 14 Market Split by Mechanism of Action Analysis 2022 - 2034
14.1 Cell Wall Synthesis Inhibitors
14.1.1 Global Antibiotics Revenue Market Size and Share by Cell Wall Synthesis Inhibitors 2022 - 2034
14.2 Protein Synthesis Inhibitors
14.2.1 Global Antibiotics Revenue Market Size and Share by Protein Synthesis Inhibitors 2022 - 2034
14.3 DNA Synthesis Inhibitors
14.3.1 Global Antibiotics Revenue Market Size and Share by DNA Synthesis Inhibitors 2022 - 2034
14.4 RNA Synthesis Inhibitors
14.4.1 Global Antibiotics Revenue Market Size and Share by RNA Synthesis Inhibitors 2022 - 2034
14.5 Mycolic Acid Inhibitors
14.5.1 Global Antibiotics Revenue Market Size and Share by Mycolic Acid Inhibitors 2022 - 2034
14.6 Others
14.6.1 Global Antibiotics Revenue Market Size and Share by Others 2022 - 2034
Chapter 15 Market Split by Spectrum Of Activity Analysis 2022 - 2034
15.1 Broad-spectrum Antibiotic
15.1.1 Global Antibiotics Revenue Market Size and Share by Broad-spectrum Antibiotic 2022 - 2034
15.2 Narrow-spectrum Antibiotic
15.2.1 Global Antibiotics Revenue Market Size and Share by Narrow-spectrum Antibiotic 2022 - 2034
Chapter 16 Market Split by Infection Type Analysis 2022 - 2034
16.1 Respiratory Tract Infections (RTIs)
16.1.1 Global Antibiotics Revenue Market Size and Share by Respiratory Tract Infections (RTIs) 2022 - 2034
16.2 Urinary Tract Infections (UTIs)
16.2.1 Global Antibiotics Revenue Market Size and Share by Urinary Tract Infections (UTIs) 2022 - 2034
16.3 Skin and Soft Tissue Infections (SSTIs)
16.3.1 Global Antibiotics Revenue Market Size and Share by Skin and Soft Tissue Infections (SSTIs) 2022 - 2034
16.4 Gastrointestinal Infections
16.4.1 Global Antibiotics Revenue Market Size and Share by Gastrointestinal Infections 2022 - 2034
16.5 Sexually Transmitted Infections (STIs)
16.5.1 Global Antibiotics Revenue Market Size and Share by Sexually Transmitted Infections (STIs) 2022 - 2034
16.6 Bloodstream Infections (Sepsis)
16.6.1 Global Antibiotics Revenue Market Size and Share by Bloodstrea